"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"

Acibadem University100 enrolled

Overview

The aim of this study is to evaluate the associations of self-compassion and self-efficacy levels with symptom severity, functional status, and quality of life in individuals with Parkinson's disease.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Parkinson Disease Physical Disability

Interventions

Self-Report Questionnaire AssessmentOTHER

This study does not involve any therapeutic intervention. Participants will complete a set of self-report questionnaires assessing self-compassion, self-efficacy, symptom severity, functional status, and quality of life. Data will be collected in a single session for observational analysis.

Eligibility

Sex: ALLMin age: 40 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of Parkinson's disease * Hoehn and Yahr stage 1-3 * Age 40 to 85 years * Mini-Mental State Examination (MMSE) score ≥24 * Sufficient cognitive function to communicate and complete study assessments * Attending the Movement Disorders Outpatient Clinic, Department of Neurology * Able and willing to provide written informed consent Exclusion Criteria: * Major depressive disorder or psychotic disorder * Advanced dementia * Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension) * Severe cardiovascular or respiratory disease * Additional neurological or orthopedic conditions that may affect assessment performance * Severe visual or hearing impairment that could interfere with study assessments * Inability to cooperate with the physiotherapist during study assessments

Locations (1)

Acibadem University

Istanbul, Turkey, Turkey (Türkiye)

RECRUITING

Outcomes

Primary Outcomes

Self-Compassion Scale (SCS) Total Score

Self-Compassion Scale (SCS) total score. The Self-Compassion Scale consists of 26 items scored on a 1- to 5-point Likert scale. Total scores range from 1 to 5 (calculated as the mean of all items), with higher scores indicating greater self-compassion (better outcome).

Time frame: Baseline (at the time of questionnaire completion)

Self-Efficacy for Managing Chronic Disease 6-Item Scale Total Score

Self-Efficacy for Managing Chronic Disease 6-Item Scale total score. The scale consists of 6 items scored from 1 (not at all confident) to 10 (totally confident). The total score is calculated as the mean of the six items, ranging from 1 to 10, with higher scores indicating greater self-efficacy for managing chronic disease (better outcome).

Time frame: Baseline (at the time of questionnaire completion)

Unified Parkinson's Disease Rating Scale (UPDRS) Total Score

Unified Parkinson's Disease Rating Scale (UPDRS) total score. The total score ranges from 0 to 199, with higher scores indicating greater Parkinson's disease severity and worse clinical status (worse outcome).

Time frame: Baseline (at the time of questionnaire completion)

Secondary Outcomes

Timed Up and Go (TUG) Test Completion Time in Seconds

Functional mobility will be measured using the Timed Up and Go (TUG) test. The time required to stand up from a chair, walk 3 meters, turn, return, and sit down will be recorded in seconds. Longer times indicate poorer functional mobility.

Time frame: Baseline (at the time of questionnaire completion)

Six-Minute Walk Test (6MWT) Distance in Meters

Functional exercise capacity will be measured using the Six-Minute Walk Test (6MWT). The total distance walked in six minutes will be recorded in meters. Greater distances indicate better functional capacity.

Central Contacts

Nuray ALACA

CONTACT

05324251290 nuray.alaca@acibadem.edu.tr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.